ArticleCureus2025
Contralateral Adrenal Metastasis from Clear Cell Renal Cell Carcinoma After Right Radical Nephrectomy and Caval Thrombectomy: A Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contralateral adrenal metastasis from clear cell renal cell carcinoma (ccRCC) is considered an exceptionally uncommon event. Early detection is crucial for optimal management, especially in high-grade tumors with vascular invasion. We report a 50-year-old woman with type 2 diabetes mellitus and obesity (BMI 29) who underwent right radical nephrectomy and inferior vena cava thrombectomy for pT3bpNxMx ccRCC. One year postoperatively, imaging revealed a solitary metachronous metastasis in the left adrenal gland, which progressively enlarged despite being under systemic therapy with pembrolizumab. A laparoscopic transabdominal adrenalectomy was successfully performed, and histopathology confirmed metastatic ccRCC. Postoperative recovery was uneventful, with adequate endocrine management ensuring normal adrenal function. A review of literature suggests that contralateral adrenal metastasis at presentation is rare and usually associated with large, high-grade primary tumors. The mechanism may involve hematogenous spread through the renal and adrenal venous systems. Surgical resection remains the mainstay of treatment, offering the best outcomes in selected patients without extra-adrenal disease. Long-term oncologic surveillance is essential in patients with ccRCC. In oligometastatic disease, adrenalectomy can offer significant diagnostic and therapeutic value. A multidisciplinary approach is crucial for optimizing outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.